Julia Ramirez Julia Ramirez

FDA Expands Mounjaro Approval to Include Cardiovascular Risk Reduction in Type 2 Diabetes

The U.S. Food and Drug Administration has expanded the approved use of Mounjaro (tirzepatide) to include reducing the risk of major cardiovascular events in adults with type 2 diabetes who are at high risk for cardiovascular disease.

The FDA decision, announced August 28, 2026, adds an important cardiovascular indication to a medication already used to help manage blood glucose in people with type 2 diabetes. Learn more…

Read More
Julia Ramirez Julia Ramirez

Should You Be Worried About the Recent Lettuce Outbreak?

You've probably seen the headlines about the recent lettuce outbreak. But how concerned should you actually be? The answer may surprise you. Here's what the science says, who's most at risk, and when symptoms warrant a call to your physician.

Read more on our blog.

Read More
Julia Ramirez Julia Ramirez

How Sugar Affects Your Heart & Metabolic Health

Emerging evidence from major health institutions shows that routine consumption of added sugars plays a meaningful role in metabolic imbalance and cardiovascular risk. Let’s explore together…

Read More